Global Europe Medical Imaging AI Market Analysis, Opportunities and Forecast 2024-2032
Europe Medical Imaging AI market valued at USD 0.95B in 2023, projected to reach USD 7.05B by 2032 at a 26.5% CAGR, driven by rising imaging volumes.
$0.9B
$7.9B
26.5%
North America
Executive Summary
The Europe Medical Imaging AI market, valued at USD 0.95 billion in 2023, is projected to reach USD 7.05 billion by 2032, growing at a CAGR of 26.5%. Key growth drivers include rising radiologist shortages, increasing imaging volumes, EU regulatory frameworks supporting AI adoption, and major investments by Siemens Healthineers, Philips, and emerging AI-native firms. Radiology and cardiology applications dominate current adoption, while oncology and neurology represent high-growth frontiers. Germany, the United Kingdom, and France lead regional adoption, supported by robust digital health infrastructure. Challenges include data privacy compliance under GDPR, interoperability barriers, and clinician trust gaps. The market presents significant investment opportunities in AI-powered diagnostic platforms, cloud-based imaging solutions, and point-of-care AI tools across European healthcare systems.
Key Highlights
Market valued at USD 0.9B in 2023, growing at 26.5% CAGR
North America leads with largest regional market share
Asia Pacific is the fastest-growing regional market
Market Overview
Market Context
The Medical Imaging AI market is shaped by rapid technological innovation, shifting consumer preferences, and increasing regulatory focus on sustainability and compliance.
Europe accounts for approximately 28% of the global medical imaging AI market, with rapid adoption driven by aging populations, rising chronic disease burden, and strong government-backed digital health strategies. The EU AI Act and MDR framework provide structured regulatory pathways for AI-based medical devices. Germany, the UK, France, and the Nordics lead clinical integration of AI into radiology, cardiology, and pathology workflows.
Market Stage
High growth
Adoption Level
Growing
Key Trends
Market Forecast & Data
Base Year (2023)
$0.9B
Forecast (2032)
$7.9B
CAGR (2024-2032)
26.5%
| Year | Market size ($ Billion) |
|---|---|
| 2023Base year | $0.95B |
| 2024 | $1.20B |
| 2025 | $1.52B |
| 2026 | $1.92B |
| 2027 | $2.43B |
| 2028 | $3.08B |
| 2029 | $3.89B |
| 2030 | $4.92B |
| 2031 | $6.23B |
| 2032 | $7.88B |
The market is forecast to maintain robust growth through 2032, driven by expanding applications, new entrant investments, and emerging market adoption.
| Region | Market share | Growth rate | Largest market |
|---|---|---|---|
| North America | 38.0% | 26.5% | United States |
| Europe | 28.0% | 23.9% | Germany |
| Asia Pacific | 26.0% | 29.2% | China |
| Rest of World | 8.0% | 21.2% | Brazil |
North America
#1Largest market: United States
Europe
#2Largest market: Germany
Market Dynamics
- Rising radiologist shortages and increasing diagnostic imaging volumes across Europe
- EU regulatory frameworks supporting AI-enabled medical device approvals
- Growing investments in digital health infrastructure and AI R&D
Market Segmentation
| Segment | Share |
|---|---|
| Type ADominant Medical Imaging AI segment. | 55.0% |
| Type BGrowing Medical Imaging AI segment. | 45.0% |
| Total | 100.0% |
By End User
- Enterprise
- SMB
- Government
Regional Analysis
North America
Lead: United StatesLargest market driven by technology adoption and R&D investment.
Europe
Lead: GermanyStrong regulatory framework supports market growth.
Asia Pacific
Lead: ChinaFastest growing region driven by rapid industrialization.
Rest of World
Lead: BrazilEmerging markets present untapped growth opportunities.
Country-Level Analysis
| Country | Share | Growth |
|---|---|---|
| United States | 28.0% | +25.2% |
| China | 18.0% | +31.8% |
| Germany | 9.0% | +22.5% |
| Japan | 7.0% | +21.2% |
| United Kingdom | 6.0% | +23.3% |
Competitive Landscape
Siemens Healthineers
Germany
Dominant player with comprehensive AI-powered imaging portfolio including AI-Rad Companion, integrated across CT, MRI, and molecular imaging platforms.
Philips Healthcare
Netherlands
Strong presence in AI-enabled CT and MRI solutions, advancing precision diagnosis with integrated informatics and AI-driven clinical decision support.
Aidoc
Israel
AI-native company specializing in acute care imaging AI for radiology workflow triage, with growing European hospital deployments.
Recent Developments
Launched next-generation Medical Imaging AI platform with enhanced AI-driven capabilities.
Expanded market presence through strategic partnership in Asia Pacific region.
Reported record annual revenue growth driven by strong Medical Imaging AI product demand.
Regulatory Landscape
Research Methodology
Primary research
- Expert interviews
- Industry surveys
Secondary research
- Industry reports
- Company financials
- Government databases
Validation: Triangulation method with cross-referencing multiple data sources
Strategic Takeaways
High-growth Medical Imaging AI sector offers compelling entry opportunities
Focus on technology differentiation to capture market share
Frequently Asked Questions
Related research
Reports in the same field, each with its base-year figure and the growth rate it is published at.
- Medical ImagingGlobal United States Medical Imaging AI Market$1.1B · 27.5% CAGR
- Medical ImagingGlobal Medical Imaging AI Market$1.4B · 22.5% CAGR
- Medical ImagingGlobal North America Medical Imaging AI Market$1.5B · 24.5% CAGR
- Medical ImagingGlobal Asia Pacific Medical Imaging AI Market$2.4B · 22.5% CAGR
- Medical DevicesGlobal Europe Wearable Medical Devices Market$12.5B · 12.5% CAGR
- BiotechnologyGlobal Europe Gene Therapy Market$1.4B · 20% CAGR